The ophthalmology department was able to confirm a left CRAO, and the lab tests confirmed the presence of inflammation (elevated IL-6) and elevated clotting (D-dimer), which pointed to CRAO occurring after the patient's COVID-19 diagnosis. The gene discussed is IL6; the disease is COVID-19.